NEW YORK (360Dx) — Sienna Cancer Diagnostics announced today that it has finalized the terms of a A$5.2 million ($3.6 million) private placement and rights issue.

Melbourne, Australia-based Sienna said it will sell approximately 27 million newly issued shares at A$.06 apiece to Merchant Opportunities Fund and private investor David Williams in order to raise about A$1.6 million.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.